vs
Idexx Laboratories（IDXX）与Trade Desk (The)（TTD）财务数据对比。点击上方公司名可切换其他公司
Idexx Laboratories的季度营收约是Trade Desk (The)的1.3倍（$1.1B vs $846.8M），Idexx Laboratories净利率更高（22.8% vs 22.1%，领先0.7%），Idexx Laboratories同比增速更快（14.3% vs 14.3%），Idexx Laboratories自由现金流更多（$326.3M vs $285.3M），过去两年Trade Desk (The)的营收复合增速更高（31.3% vs 6.4%）
IDEXX Laboratories是1983年成立的美国跨国企业，主营伴侣动物诊疗、畜禽养殖、水质检测、乳制品领域相关产品与服务的研发、生产及分销，总部位于缅因州韦斯特布鲁克，欧洲、中东及非洲地区分部设于荷兰霍夫多普。
The Trade Desk是来自美国的跨国科技企业，专注于实时程序化营销自动化领域的技术、产品与服务研发，可实现面向用户的个性化数字内容分发，为全球广告营销行业客户提供专业解决方案。
IDXX vs TTD — 直观对比
营收规模更大
IDXX
是对方的1.3倍
$846.8M
营收增速更快
IDXX
高出0.0%
14.3%
净利率更高
IDXX
高出0.7%
22.1%
自由现金流更多
IDXX
多$41.1M
$285.3M
两年增速更快
TTD
近两年复合增速
6.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $846.8M |
| 净利润 | $248.2M | $186.9M |
| 毛利率 | 60.3% | 80.7% |
| 营业利润率 | 28.9% | 30.3% |
| 净利率 | 22.8% | 22.1% |
| 营收同比 | 14.3% | 14.3% |
| 净利润同比 | 14.8% | 2.6% |
| 每股收益（稀释后） | $3.09 | $0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDXXTTD
| Q4 25 | $1.1B | $846.8M | ||
| Q3 25 | $1.1B | $739.4M | ||
| Q2 25 | $1.1B | $694.0M | ||
| Q1 25 | $998.4M | $616.0M | ||
| Q4 24 | $954.3M | $741.0M | ||
| Q3 24 | $975.5M | $628.0M | ||
| Q2 24 | $1.0B | $584.5M | ||
| Q1 24 | $964.1M | $491.3M |
净利润IDXXTTD
| Q4 25 | $248.2M | $186.9M | ||
| Q3 25 | $274.6M | $115.5M | ||
| Q2 25 | $294.0M | $90.1M | ||
| Q1 25 | $242.7M | $50.7M | ||
| Q4 24 | $216.1M | $182.2M | ||
| Q3 24 | $232.8M | $94.2M | ||
| Q2 24 | $203.3M | $85.0M | ||
| Q1 24 | $235.6M | $31.7M |
毛利率IDXXTTD
| Q4 25 | 60.3% | 80.7% | ||
| Q3 25 | 61.8% | 78.1% | ||
| Q2 25 | 62.6% | 78.2% | ||
| Q1 25 | 62.4% | 76.8% | ||
| Q4 24 | 59.8% | 81.7% | ||
| Q3 24 | 61.1% | 80.5% | ||
| Q2 24 | 61.7% | 81.1% | ||
| Q1 24 | 61.5% | 78.9% |
营业利润率IDXXTTD
| Q4 25 | 28.9% | 30.3% | ||
| Q3 25 | 32.1% | 21.8% | ||
| Q2 25 | 33.6% | 16.8% | ||
| Q1 25 | 31.7% | 8.8% | ||
| Q4 24 | 27.4% | 26.4% | ||
| Q3 24 | 31.2% | 17.3% | ||
| Q2 24 | 26.3% | 16.2% | ||
| Q1 24 | 31.0% | 5.8% |
净利率IDXXTTD
| Q4 25 | 22.8% | 22.1% | ||
| Q3 25 | 24.8% | 15.6% | ||
| Q2 25 | 26.5% | 13.0% | ||
| Q1 25 | 24.3% | 8.2% | ||
| Q4 24 | 22.7% | 24.6% | ||
| Q3 24 | 23.9% | 15.0% | ||
| Q2 24 | 20.3% | 14.5% | ||
| Q1 24 | 24.4% | 6.4% |
每股收益（稀释后）IDXXTTD
| Q4 25 | $3.09 | $0.39 | ||
| Q3 25 | $3.40 | $0.23 | ||
| Q2 25 | $3.63 | $0.18 | ||
| Q1 25 | $2.96 | $0.10 | ||
| Q4 24 | $2.62 | $0.36 | ||
| Q3 24 | $2.80 | $0.19 | ||
| Q2 24 | $2.44 | $0.17 | ||
| Q1 24 | $2.81 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.1M | $1.3B |
| 总债务越低越好 | $450.0M | — |
| 股东权益账面价值 | $1.6B | $2.5B |
| 总资产 | $3.4B | $6.2B |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
现金及短期投资IDXXTTD
| Q4 25 | $180.1M | $1.3B | ||
| Q3 25 | $208.2M | $1.4B | ||
| Q2 25 | $164.6M | $1.7B | ||
| Q1 25 | $164.0M | $1.7B | ||
| Q4 24 | $288.3M | $1.9B | ||
| Q3 24 | $308.6M | $1.7B | ||
| Q2 24 | $401.6M | $1.5B | ||
| Q1 24 | $397.4M | $1.4B |
总债务IDXXTTD
| Q4 25 | $450.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $617.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IDXXTTD
| Q4 25 | $1.6B | $2.5B | ||
| Q3 25 | $1.6B | $2.6B | ||
| Q2 25 | $1.5B | $2.7B | ||
| Q1 25 | $1.4B | $2.7B | ||
| Q4 24 | $1.6B | $2.9B | ||
| Q3 24 | $1.6B | $2.6B | ||
| Q2 24 | $1.6B | $2.4B | ||
| Q1 24 | $1.6B | $2.2B |
总资产IDXXTTD
| Q4 25 | $3.4B | $6.2B | ||
| Q3 25 | $3.4B | $5.9B | ||
| Q2 25 | $3.3B | $6.0B | ||
| Q1 25 | $3.2B | $5.7B | ||
| Q4 24 | $3.3B | $6.1B | ||
| Q3 24 | $3.4B | $5.5B | ||
| Q2 24 | $3.4B | $5.2B | ||
| Q1 24 | $3.4B | $4.7B |
负债/权益比IDXXTTD
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.39× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $355.8M | $311.6M |
| 自由现金流经营现金流 - 资本支出 | $326.3M | $285.3M |
| 自由现金流率自由现金流/营收 | 29.9% | 33.7% |
| 资本支出强度资本支出/营收 | 2.7% | 3.1% |
| 现金转化率经营现金流/净利润 | 1.43× | 1.67× |
| 过去12个月自由现金流最近4个季度 | $1.1B | $795.7M |
8季度趋势，按日历期对齐
经营现金流IDXXTTD
| Q4 25 | $355.8M | $311.6M | ||
| Q3 25 | $402.3M | $224.7M | ||
| Q2 25 | $185.7M | $165.0M | ||
| Q1 25 | $238.0M | $291.4M | ||
| Q4 24 | $262.0M | $199.4M | ||
| Q3 24 | $220.1M | $273.3M | ||
| Q2 24 | $248.3M | $81.3M | ||
| Q1 24 | $198.6M | $185.5M |
自由现金流IDXXTTD
| Q4 25 | $326.3M | $285.3M | ||
| Q3 25 | $371.2M | $158.3M | ||
| Q2 25 | $151.6M | $119.8M | ||
| Q1 25 | $207.9M | $232.3M | ||
| Q4 24 | $232.8M | $179.2M | ||
| Q3 24 | $192.0M | $224.6M | ||
| Q2 24 | $215.0M | $59.1M | ||
| Q1 24 | $168.3M | $178.2M |
自由现金流率IDXXTTD
| Q4 25 | 29.9% | 33.7% | ||
| Q3 25 | 33.6% | 21.4% | ||
| Q2 25 | 13.7% | 17.3% | ||
| Q1 25 | 20.8% | 37.7% | ||
| Q4 24 | 24.4% | 24.2% | ||
| Q3 24 | 19.7% | 35.8% | ||
| Q2 24 | 21.4% | 10.1% | ||
| Q1 24 | 17.5% | 36.3% |
资本支出强度IDXXTTD
| Q4 25 | 2.7% | 3.1% | ||
| Q3 25 | 2.8% | 9.0% | ||
| Q2 25 | 3.1% | 6.5% | ||
| Q1 25 | 3.0% | 9.6% | ||
| Q4 24 | 3.1% | 2.7% | ||
| Q3 24 | 2.9% | 7.8% | ||
| Q2 24 | 3.3% | 3.8% | ||
| Q1 24 | 3.1% | 1.5% |
现金转化率IDXXTTD
| Q4 25 | 1.43× | 1.67× | ||
| Q3 25 | 1.47× | 1.94× | ||
| Q2 25 | 0.63× | 1.83× | ||
| Q1 25 | 0.98× | 5.75× | ||
| Q4 24 | 1.21× | 1.09× | ||
| Q3 24 | 0.95× | 2.90× | ||
| Q2 24 | 1.22× | 0.96× | ||
| Q1 24 | 0.84× | 5.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
TTD
| Other | $427.2M | 50% |
| Non Us | $419.6M | 50% |
